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Abstract
Advances in next-generation sequencing technology have enabled systematic exploration of the contribution of rare
variation to Mendelian and complex diseases. Although it is well known that population stratification can generate spurious
associations with common alleles, its impact on rare variant association methods remains poorly understood. Here, we
performed exhaustive coalescent simulations with demographic parameters calibrated from exome sequence data to
evaluate the performance of nine rare variant association methods in the presence of fine-scale population structure. We
find that all methods have an inflated spurious association rate for parameter values that are consistent with levels of
differentiation typical of European populations. For example, at a nominal significance level of 5%, some test statistics have
a spurious association rate as high as 40%. Finally, we empirically assess the impact of population stratification in a large
data set of 4,298 European American exomes. Our results have important implications for the design, analysis, and
interpretation of rare variant genome-wide association studies.
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Introduction
Population structure can be a strong confounding factor in
association studies [1–4], and accounting for it can be important,
even in cases where seemingly homogeneous ethnic populations
are sampled. For example, low yet detectable levels of population
structure have been reported in samples from Icelandic [5], British
[6], and French Canadian populations [7] as well as in European
Americans [8,9]. The effects of population structure on association
tests have largely been explored in the context of common genetic
variation [6,10]. However, as common variants have been unable
to account for a significant proportion of complex disease
heritability [11,12], there is increasing interest in systematically
evaluating the contribution of rare variants to disease.
To this end, a large number of rare variant association test
statistics have been developed (reviewed in Bansal et al. [13] and
Asimit and Zeggini [14]) and used to identify a growing catalog of
rare alleles that may influence disease risk [13,14]. One of the
main statistical approaches used to date has been collapsing of rare
variants in order to increase statistical power over single variant
tests [13,15,16]. However, collapsing of rare variants also has the
potential to increase the power to detect associations due to
population stratification. Furthermore, previous studies have
shown that large sample sizes are needed to obtain sufficient
power to robustly associate rare variants with complex traits
[13,17], thus increasing the likelihood of sampling individuals from
populations with unrecognized structure. We will refer to the
elevation in or inflation of significance rates as the spurious
association rate (SAR) throughout the rest of the paper to
emphasize the point that population stratification causes genuine
associations between genotypes at a locus and a phenotype, but
such associations are due to genetic substructure rather than alleles
causally related to the trait.
Two recent studies have explored how rare variant association
methods perform in the presence of population stratification.
Tintle et al. [18] used exon pilot data of the 1000 genomes project
[19] and found that, as expected, the SAR is inflated when
associations are performed in samples drawn from geographically
diverse populations. Specifically, their analysis was performed on
individuals of Asian, European, and African ancestry pooled
together. They found that taking covariates from a principal
component analysis (PCA) was generally sufficient to reduce the
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SAR. A second study by Mathieson and McVean [20] developed a
biogeographic model where phenotypic outliers are sampled from
one geographic locale. Similar to Tintle et al. [18], Mathieson and
McVean [20] primarily focused on the effects of global population
structure, which leads to high SARs. Interestingly, PCA was
unable to correct for population stratification in the biogeographic
model, illustrating that particular types of structure are more
difficult to control for in association studies. Mathieson and
McVean [20] also extended their models to more modest levels of
population structure, and found qualitatively similar results.
Although these two studies have provided insights into the
behavior of rare variant association studies in the presence of
population structure, several important questions remain. In
particular, the quantitative impact of fine-scale population
structure is not well defined. Indeed, as large sample sizes are
necessary to detect associations with rare variants [13,17,21,22],
fine-scale population structure is likely to be present in many
datasets. Moreover, there have been no systematic analyses of how
sensitive different rare variant association methods are to
population structure. To address these issues, we comprehensively
evaluated the robustness of nine rare variant association methods
to modest levels of population structure. Further, we investigated
how the power of the methods changes when in the presence of
population structure and empirically assessed the SAR in a large
exome dataset [17].
Materials and Methods
Rare Variant Association Methods
We evaluated nine rare variant association methods: the
collapsed x2 test, the collapsed Fisher’s Exact Test (FET), the
Weighted Sum Statistic (WSS) [23], Variable Threshold (VT)
[24], RareCover [25], and four methods implemented under a
logistic regression framework. The logistic regression methods
include a collapsed variant test [15] where variants with a
MAF,1% are collapsed into a single class (i.e. logit Y = a+ba6I,
where I is encoded as 1 for any variant with a MAF#1% or 0 for
no such variant), a StepUp test [26], a StepDown test (different
from StepUp only in optimization strategy), and the Combined
Multivariate and Collapsing (CMC) method that analyzes
common and rare variants jointly, but as separate covariates
[15]. These methods were implemented in a Java program
CCRARE, which is available at http://akeylab.gs.washington.
edu/downloads.html, and uses the library Math Commons 2.1
(http://commons.apache.org/math/index.html). We define a
variant as rare if it has a MAF#1%, and except for CMC and
VT, are the only variants analyzed. For a detailed description of
each method see Table S1 in File S1.
For all analyses, statistical significance was determined empir-
ically using permutations. We performed 1,000 permutations for
each test statistic unless specified otherwise, which is sufficient to
evaluate a a=0.05 significance threshold. For computational
efficiency, we used a rejection procedure, which stops permuting
once more than a61,000 statistics are greater than the test
statistic. The p-values are thus not estimated in the full 1,000
permutations, but the approximation is useful for testing
significance at a particular threshold [23,25]. All p-values were
calculated as (k0+1)/(k +1) where k0 are the number of
permutations with a more significant test statistic than the original
test and k are the current number of permutations calculated. The
test was stopped when k0$ a61,000. We used a a of 5% for
computational efficiency given the large parameter space we are
exploring.
Methodological Theory for Confounding
To simulate a confounding effect due to population structure,
we adapt a previously described approach [2,27–29]. To calculate
the proportion of cases and controls that are sampled from each
subpopulation, we allowed differences in disease risk between
subpopulations where the probability an individual has a disease,
P(d = c|i), is conditional on the ith subpopulation. Furthermore, we
denote the probability that an individual is drawn from the ith
subpopulation as P(i). Intuitively, P(i) can be interpreted as the
proportion of the sample that is selected from subpopulation i,
thus,
PN
i~1 P(i)~1. Using Bayes theorem, we can calculate the
probability of drawing an individual from the ith subpopulation
given either case (c) or control (c) status as:
P(iDd~c)~
P(d~cDi)|P(i)
P(d~c)
ð1Þ
where
P(d~c)~
XN
i~1
P(d~cDi)|P(i) ð2Þ
[29] and N is the number of subpopulations. To obtain the
analogous probabilities for controls, c is substituted with c in the
above equations. For any given subpopulation,
P(d~cDi)zP(d~cDi)~1.
For each simulated scenario, we randomly paired haplotypes
within each subpopulation to produce diploid individuals. Unless
otherwise noted, we randomly sampled without replacement 1,000
cases and 1,000 controls from the subpopulations based on their
disease probability:
ncDi~m|
P(iDd~c)PN
j~1 P(jDd~c)
ð3Þ
where nc|i is the number of cases out of m (1,000 unless otherwise
noted) that come from the ith subpopulation.
Calibrating a Demographic Model
We used the strategy of Schaffner et al. [30] to calibrate a
demographic model with European population structure (see
Figure 1 and Figure S1A in File S1) that approximates empirical
patterns of DNA sequence variation. We chose a five-subpopu-
lation model as this provides flexibility in studying how prevalence
Figure 1. Schematic of demographic model used in the
simulations. Parameter values were inferred by calibrating to patterns
of variation in exome data from 316 European Americans.
doi:10.1371/journal.pone.0065834.g001
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differences, levels of differentiation, and ascertainment strategies
influence rare variant association methods. The simulation
parameters were initially calibrated to 316 European American
exomes sequenced as part of the NHLBI Exome Sequencing
Project (ESP; http://snp.gs.washington.edu/EVS/) [17]. We
calculated the root mean square error (RMSE), an estimate of
goodness of fit, between observed and simulated data for the
following statistics: linkage disequilibrium (r2) (with bins of
nucleotide distance spaced by 100 kb sections), Tajima’s D,
nucleotide diversity (p), and the site frequency spectrum. In
addition, we estimated the mean and mean squared error of FST
for variants with a minor allele frequency (MAF) $0.05 from eight
European populations (N= 158) of the Human Genome Diversity
Project (HGDP) data set [31], which was also used in our RMSE
calculations. Note, one of each related pair in the HGDP samples
was removed, and imputation of missing genotypes was performed
as previously described [32].
To calculate these statistics in the exome data, we divided the
genome into 1 Mb windows. Ten of these windows were randomly
selected, with replacement, and concatenated to form a ‘‘genomic
region’’. This procedure was repeated 10,000 times in order to
estimate a genome-wide distribution for the various statistics to
compare to the simulated data. In the simulated data, we followed
a similar procedure by calculating the statistics defined above on
ten 1 Mb windows. In total, we performed 21 independent
replicates in order to get a good estimate of the parameters and
allow for variation in the number of segregating sites per region
(see below). The average value of each statistic was used to
calculate the RMSE. The RSME function was calculated similarly
to that described by Schaffner et al. [30]. Specifically, for RMSE
the ith statistic is:
Di~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n
Xn
j~1
( Xij{ Yij)
2
se2Yij
vuut ð4Þ
where Yij is the mean of the 10,000 replicates and se
2
Yij
is the
mean squared error. Some of the statistics are distributions of
values, and we used different number of bins to summarize the
distributions (r2 by physical genomic distance [n=10] and the site
frequency spectrum by minor allele frequency [n=7]), which were
indexed by j in Equation 4. For the other statistics, n=1. Xij is the
average for the simulated data of the 21 replicates for statistic i bin
j. The combined RMSE across all statistics is:
Dtot~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
5
X5
i~1
D2i
r
ð5Þ
Optimization was performed using a genetic algorithm until no
further improvement in the RMSE was observed for 10 iterations.
We also performed Kolmogoroff-Smirnov (K-S) tests to
compare the distributions of the number of segregating sites in
the observed and simulated data. To achieve a better fit for this
statistic, the scaled population mutation rate h=4Nem was defined
by two parameters, an average (m) and a deviation from that
average (d) using the function mk = m+(((np –1)/2)-k)6d where
window k had a mutation rate of mk and np are the number of
replicates. We used an odd number (i.e. 21) so that mk = m for one
replicate and the other values were centered on m.
Coalescent Simulations To Evaluate the SAR and Power
Using the parameter values inferred as described above (see
Figure 1B), we simulated 10,000 haplotypes (2,000 from each of
the five subpopulations) using coalescent simulations with MSMS
[33] of length 41 kb, the average gene size in genomic coordinates.
This resulted in 1,000 diploid individuals from each subpopulation
and 5,000 individuals overall.
We selected 1,000 cases and 1,000 controls using Equation 3,
which requires specifying the disease risk of individuals in the ith
subpopulation, P(d = c|i), and the proportion of individuals
sampled from each subpopulation, P(i). We varied these param-
eters over a wide range of values. Specifically, we set P(d = c |
i = 1) = 0.03+Y, P(d = c | i = 2) = 0.03+Y/2, P(d = c | i = 3) = 0.03,
P(d = c | i = 4) = 0.03-Y/2, and P(d = c | i = 5) = 0.03-Y, and
considered values of Y= [-0.03, -0.02, …,0.03]. When Y=0 all
subpopulations have a disease prevalence of 0.03. Similarly, to
define the proportion of individuals from each subpopulation we
set P(i = 1) = 0.2+X, P(i = 2= 0.2+X/2, P(i = 3) = 0.2,
P(i = 4) = 0.2-X/2, and P(i = 5) = 0.2-X and considered values of
X= [20.2, 20.1, …, 0.2]. When X=0, individuals in all
subpopulations have a 20% chance of being sampled. All pairwise
testing of X and Y values results in 35 distinct combinations. The
condition of Y=0 and X=0 is equivalent to the situation of ‘‘no
confounding’’ with population structure [2]. We evaluated each set
of parameters with 1,000 ‘‘gene’’ regions and estimated the
proportion significant at the a=0.05 level.
We also evaluated the power of logistic regression based
methods, which can incorporate covariates. To this end, we used
the same simulations generated with the five-population model
and the same population risk confounding framework (see Figure
S1C in File S1), but reduced the number of parameters by fixing
P(i)=0.2. In order to generate case/control status, we used a
logistic regression model where variants with a MAF#1% could
modify risk with odds ratios (ORs) of 1.0, 1.5, 2.0, 3.0, 4.0, or 5.0.
After all individuals in each subpopulation were assigned a case/
control status from the logistic regression, we selected the number
of cases and controls from each subpopulation in agreement with
the proportion given by Equation 3. This process was replicated
for 500 regions, each with a minimum of five rare variants. We
also evaluated the power and SAR with zero, one, or ten PCs with
four tests (T1, CMC, StepUp, and StepDown) that could
incorporate covariates. Five rare variants was used so that each
segment had similar potential of being significant.
To explicitly evaluate how the magnitude of population
structure influences the SAR, we also considered a simple model
with two subpopulations and varied the time of population
splitting (see Figure S1D in File S1). Specifically, we considered
six-generation times of population splitting that span the range
estimated in the calibrated model (4Ne6[1.5, 2.0, …4.0]610
23) as
well as a divergence time of zero (i.e. a single panmictic
population). We also included the migration rate estimate and
other parameters of the calibrated model. For each time of
population splitting, we simulated 4,000 haplotypes (2,000 diploid
individuals) in each of the two populations. We then sampled
1,000 cases and 1,000 controls from Equation 3 by fixing the
values of P(i) to 0.5 for each subpopulation and calculating disease
risks according to the equations P(d = c|i = 1) = 0.02+X and
P(d = c|i = 2) = 0.02-X for values of X= [0.000, 0.005, …, 0.020].
Analysis of Spurious Associations in a Large Exome
Dataset
To empirically evaluate the SAR, we analyzed exome sequences
from a sample of 4,298 European Americans with modest, but
statistically significant, levels of population stratification (http://
Pop. Stratification in Rare Variant Assoc. Tests
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snp.gs.washington.edu/EVS/) [17]. We sampled 1,000 cases and
1,000 controls from the dataset such that the probability of being a
case is a function of where the individual is located in PC space.
Thus, individuals that cluster together in PC space have similar
likelihoods of being cases (or controls), thus mimicking the effect of
population structure. To this end, we used a logistic regression
approach to generate phenotype affection status probabilities
based on the first two PCs (Equation 6) and determined case/
Figure 2. Rare variant association methods exhibit higher than expected rates of spurious associations. Each square represents a
confounding scenario set by different values of disease risks, parameterized by Y, and the proportions of each sampled subpopulation, parameterized
by X as presented in the text. A value of 0.0 for X indicates an equal proportion of each subpopulation in the study pool and 0.00 for Y indicates an
equal disease risk. Spurious association rates (SAR) lower than 5% are represented as white, with other levels signified by sequential coloration with
red the lowest and blue the highest. Actual values of the SAR can be found in Figure S2 in File S1.
doi:10.1371/journal.pone.0065834.g002
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control status by comparing the probability to a uniformly
distributed random number:
p~log it{1(bPC1|ZPC1zbPC2|ZPC2) ð6Þ
To calculate the b values, which are measured in unit changes
of PC values (i.e., ZPC1 and ZPC2) we used the equation:
bPC~
ln(OR)
dPC
ð7Þ
where dPC is a function of the distance between the minimum and
maximum values along a PC axis and allows us to vary the
strength of PC confounding, and OR denotes the odds ratio.
Values of dPC considered were 1, K, or J of the intervening
distance between the most distant individuals, and smaller values
indicate larger differences in disease risk among individuals in PC
space.
For each combination of dPC, OR, and PC, we performed ten
replicates of an exome-wide analysis with the logistic T1 calculated
for each gene. In total, we performed 490 exome scans with a
median gene count of 14,360 (min= 14,313 and max= 14,401)
where differences in gene number are due to the individuals
sampled and a minimum of five rare variants per gene.
Results
A Calibrated Demographic Model
Through extensive simulations, we inferred parameters of a
demographic model that recapitulate patterns of variation present
in observed exome data (Figure S1A in File S1). The calibrated
demographic model has an average RMSE of 1.42, which is
similar to the values produced by Schaffner et al. [30]. The
average p-values for the number of segregating sites from the K-S
test was 0.94, consistent with a good fit between the simulated and
empirical distributions. The parameters estimated from this
procedure were then compared to an independent set of 316
European American individuals sampled from ESP, which verified
the consistency of the parameter estimates (mean RMSE=2.5148;
average K-S p-value = 0.72). As expected these values were slightly
different from the original data set, but are still within acceptable
limits. All subsequent simulated data were generated from
parameter values of our calibrated demographic model (Table
S2 in File S1).
Fine-scale Population Structure Leads to Spurious
Associations
Using the calibrated demographic model (Figure S1B in File
S1), we simulated 1,000 cases and 1,000 controls, and evaluated
the SAR of nine rare variant association methods for data
simulated under the null hypothesis of no causal disease variants.
As described in Materials and Methods, the level of confounding is
Figure 3. The effects of PCA correction on logistic CMC. The top
figure has the spurious association rate (SAR) of CMC without correcting
for population structure. The middle figure shows the SAR of CMC when
a single PC is included as a covariate. The bottom figure shows the SAR
of CMC when 10 PCs are included as covariates. Each square represents
a confounding scenario parameterized by X and Y as presented in the
text. SAR lower than 5% are represented as white, with other levels
signified by sequential coloration with red the lowest and blue the
highest. Actual values of the SAR can be found in Figure S4 in File S1.
doi:10.1371/journal.pone.0065834.g003
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determined by differences in disease prevalence among subpop-
ulations (which varied from 0% to 6% as determined by the
variable Y) and the proportion of individuals sampled from each
subpopulation (which varied from 0% to 40% as determined by
the variable X). For example, when Y=–0.03, the disease
prevalence is 0, 0.015, 0.03, 0.045, and 0.06 in subpopulations
one through five, respectively. Similarly, when X= -0.2, the
proportion of individuals sampled from subpopulations one
through five are 0, 0.10, 0.20, 0.30, and 0.40, respectively.
Simulations where the disease prevalence was identical and
individuals were sampled equally from all subpopulations (X= 0
and Y=0) yielded expected type I error rates (Figure 2; see also
Figure S2 in File S1). However, even relatively small differences in
disease prevalence in the presence of fine-scale population
structure can lead to elevated rates of spurious associations. For
example, each of the nine methods had an elevated SAR with
differences in disease prevalence as low as 4% among subpopu-
lations (Y#–0.01 and Y$0.01; Figure 2). The logistic CMC, which
simultaneously tests common and rare variation, had the highest
levels of spurious associations (a maximum SAR of 43.4% when
Y=0.03 and X=20.2; Figure 2). Although common variants may
contribute to the observed spurious associations, some of the
optimization based association methods that only examine rare
variants have SARs comparable to CMC (maximum SARs of
39.3% for StepUp and 32.4% for RareCover). Notably, these
optimization methods also have the lowest power to detect rare
variant associations (see Figure S3 in File S1).
Among the association methods considered here, the logistic
regression based methods (i.e. T1, CMC, StepUp, and StepDown)
are able to incorporate covariates. By including ten PCs, the SAR
for each of these four methods was reduced to nominal levels. As
an example, Figure 3 shows the PCA corrected results for CMC
Figure 4. SAR of rare variant association methods as a function of FST. We tested for spurious association rates at various divergence times,
presented as FST estimates for comparison with European populations in HGDP (light blue shading). The various lines represent differences in disease
risk according to the equations P(d = c|i = 1) = 0.02+ X and P(d = c|i = 2) = 0.02 2 X. The dashed black line represents the a=0.05 value used to
determine significance and the dotted lines represent the 95% confidence intervals calculated by bootstrapping.
doi:10.1371/journal.pone.0065834.g004
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with zero, one, or ten PC covariates (see also Figure S4 in File S1).
Results from the other three methods are similar and presented in
Figure S5 and S6 in File S1. Additional numbers of PCs were
explored, but were not necessary to correct for population
structure in our demographic model (data not shown). We note
that selecting the optimal number of PCs to include as covariates is
a difficult problem and the strategy to correct for structure
depends on the demographic scenario and disease risk differences
between groups [34].
We also evaluated the T1 test at a lower p-value threshold
(a=0.0001) and found comparable results (see Figure S7 and S8
in File S1). Again, the correction with 10 PCs brought the SAR to
within the expected range. The 95% confidence interval included
0 of 1000 replicates for all parameter values tested.
Correcting for Spurious Associations Reduces Power of
Rare Variant Association Methods
We next tested how correcting for population structure
influences power of rare variant association methods (Figure
S1C in File S1). We focused this analysis on the four logistic
regression based methods as they can incorporate PC covariates.
All four methods had higher power in simulations without
population structure (and no PC correction), and in some cases
significantly so (Figure 4). Intuitively, this makes sense as
correcting for confounding can mask true signal in cases where
causal variants and confounding are correlated. For example, all
methods incurred the greatest loss of power when levels of
confounding were higher (Figure 4).
Nonetheless, it is still possible to have good power in samples
with population structure. As expected, the logistic T1 test
performed the best, as this is the same model we used to generate
the genotype-phenotype map. CMC also performed well, but the
Figure 5. Correcting for population structure reduces the power of rare variant association methods. The figure shows the power of
logistic regression methods when including ten PC covariates. The x-axis shows the odds ratio (OR), where 1.0 is the null model. ‘‘No Structure’’
indicates simulations where power was estimated from sampling cases and controls from a single panmictic population, but still corrected for
structure. The dashed black line represents a= 0.05 and the dotted lines represent the 95% bootstrap confidence intervals.
doi:10.1371/journal.pone.0065834.g005
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StepUp and StepDown optimization methods had the lowest
power compared to the other methods, consistent with our
estimates of power in the absence of population structure (Figure
S3 in File S1).
Levels of Population Structure Necessary to Elevate the
SAR
To more precisely delineate the magnitude of population
structure necessary to inflate the SAR, we considered a simpler
demographic model of two subpopulations and varied the time of
population splitting (see Materials and Methods; Figure S1D in
File S1). All nine rare variant association methods exhibited the
expected type I error rate in the absence of population structure or
when the difference in disease prevalence was less than 1% among
subpopulations (Figure 5). However, with larger differences in
disease prevalence, the SAR can be substantially inflated, even for
levels of divergence less than or equal to that observed in
European populations within the HGDP (FST in the range of
0.01–0.025; light blue shading in Figure 5). For example, with a
difference in disease prevalence of 3%, very low levels of
differentiation (FST , 0.005), RareCover, StepUp, StepDown,
CMC, and the WSS have SARs of 0.16, 0.21, 0.19, 0.14, and
0.07, respectively. Thus, these results help refine the conditions in
which spurious associations become an important issue to rare
variant association analyses. For the logistic regression models, we
evaluated the SAR when one or ten PCs were included as
covariates. These methods recovered reasonable error rates with a
single PC (Figure S9 in File S1).
SAR in a Large European American Exome Dataset
The NHLBI Exome Sequencing Project recently described a
large, high-quality sequence data set consisting of exomes
(approximately 15,000 protein-coding genes) from 4,298 Europe-
an Americans and 2,017 African Americans [17]. As the median
coverage of this dataset was over 100x, even very rare genotypes
were called accurately. To complement the simulations described
above, we empirically assessed the SAR in the European
American samples using the logistic T1 method. We focused on
this method because it is a widely used statistic that is similar to
several other approaches such as CMC [15,16,20] and is
computationally efficient.
We generated phenotypes that are confounded with population
structure using a PCA approach as described in Materials and
Methods. For example, Figure 6 shows the probability of being a
case for each of the 4,298 European American individuals,
assuming that individuals separated by a fourth of the maximal
PC1 or PC2 distance have an OR=5 of being a case. After
assigning phenotypes, we randomly selected 1,000 cases and 1,000
controls from the European American individuals and calculated
the logistic T1 statistic on each gene that contained a minimum of
five rare variants. We repeated this analysis ten times for each of
the parameter settings as described in Materials and Methods.
The highest average SAR value from these scans was 7.07%,
which is only slightly elevated above the expected value of 5%. We
did not attempt to correct this SAR using PCA as that was how the
Figure 6. Probability of being a case as a function of PC1 and
PC2. Individuals (dots) are colored according to the logistic regression
with b values scaled so that for this example an odds ratio (OR) of 5 for
a distance of a fourth of the minimal and maximal values for each axis.
In other words, individuals separated by a fourth of the PC distance will
have an OR of 5 compared to each other. The probability of being a
case is thus indicated by the color of each dot on a scale from 0.06 to 1,
as indicated by the gradient (lower right corner).
doi:10.1371/journal.pone.0065834.g006
Table 1. Spurious association rates in the exome data.
PC1
PC2 OR 1/5 Fourth OR 1/5 Half OR 1/5 Full OR 1 OR 5 Full OR 5 Half OR 5 Fourth
OR 1/5 Fourth 0.0686 0.0548 0.0448 0.0400 0.0421 0.0501 0.0660
OR 1/5 Half 0.0683 0.0543 0.0442 0.0402 0.0425 0.0521 0.0680
OR 1/5 Full 0.0686 0.0544 0.0441 0.0397 0.0443 0.0524 0.0684
OR 1 0.0700 0.0555 0.0442 0.0389 0.0434 0.0527 0.0707
OR 5 Full 0.687 0.0522 0.0434 0.0391 0.0454 0.0541 0.0684
OR 5 Half 0.0683 0.0530 0.0441 0.0395 0.0444 0.0530 0.0689
OR 5 Fourth 0.0641 0.0494 0.0401 0.0393 0.0448 0.0539 0.0667
The values are the average spurious association rate for ten run using 1,000 cases and controls from the European Americans in the Exome Sequencing Project. These
are the rates at the 5% significance threshold for parameters defined as odds ratios (ORs) of 1/5, 1, or 5 for a fourth, half, or full distance between the minimum and
maximum for each axis: PC1 are the columns, and PC2 are the probabilities calculated for each individual. Smaller values indicate larger differences in disease risk
among individuals in PC space.
doi:10.1371/journal.pone.0065834.t001
Pop. Stratification in Rare Variant Assoc. Tests
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e65834
confounding was generated. Even with the most extreme
parameters considered in Table 1, the SAR of this European
American sample is unlikely to be problematic for the sample size
considered here and is likely due to the limited genetic
differentiation among individuals. For example, the FST between
extreme groups from the first and second PC (as identified in
Figure S10 in File S1), which have a maximal average FST of
0.011, is lower than the minimum pairwise FST observed from the
HGDP populations of 0.012. However, we note that our
simulations suggest that with larger sample sizes, and hence
higher power to detect structure, the magnitude of population
structure present in European Americans could result in elevated
rates of spurious associations.
Discussion
We have demonstrated that all rare variant association methods
considered here can yield elevated rates of spurious associations in
the presence of fine-scale population structure. Furthermore, we
showed that incorporating PCs as covariates can mitigate the
confounding effects of population structure and return spurious
association rates to be within normal type I error rates. The ability
of PCA to correct for spurious associations in our demographic
model is possibly attributable to the fact that rare and common
variants possess correlated patterns of population structure
(unpublished data). In demographic models where this is not true,
PCA may not be sufficient to properly control for spurious
associations [20]. An alternative strategy for attenuating the effects
of population structure in rare variant association methods is to
carefully match population proportions in cases and controls, and
disease risks in subpopulations [2,35,36]. This occurred in our
simulations when X= Y=0, and did not have elevated SARs.
However, matching may not always be feasible, and is particularly
difficult in situations where subtle differences in structure and
disease prevalence exist among unidentified subpopulations.
Although levels of confounding in these scenarios are weak, the
very large sample sizes necessary to robustly detect associations
with rare variants create the conditions necessary to generate
spurious associations.
The differences in disease risk among populations that we found
to generate increased SARs are plausible, and further underscore
the importance of carefully designing and interpreting rare variant
association methods. For instance, between populations of
European men there is a 2.5% to .10% difference in rates of
lung cancer, though a less striking difference among women [37].
Many other examples exist, such as differences in prevalence of
diabetes (ranging from 1.6% to 3.1% [38]) and Cystic Fibrosis
(ranging from 0.001% to 0.03% [39]). Note, it is not necessary that
differences in disease risk be genetic, only that they exist and are
confounded with population structure. For example, the true cause
of differing levels of lung cancer risk could be something other
than a genetic predisposition (e.g. differences is acceptance of
smoking between cultures), but would still be confounded with
population genetic structure.
Another issue for rare variant association methods is admixture.
Discrete populations, as we have modeled here, can be viewed as a
special case of an admixture model [29] where an admixed
individual’s probability of carrying an allele and having a
phenotype would be a weighted average of their source
populations’ values. In contrast to common variation, rare
variation is more likely to be population specific [17,22] and
subject to confounding. In addition, because admixture propor-
tions vary widely both among individuals and within an admixed
genome, global corrections such as PCA are unlikely to fully
address the heterogeneity in the strength of confounding across
loci. Clearly, additional studies are needed to better delimit the
effects of admixture on rare variant association methods, and
optimal methods for mitigating confounding.
In conclusion, although rare variant association tests are poised
to provide new insights into the genetic architecture of complex
traits, they are susceptible to spurious associations when individ-
uals are sampled from even modestly differentiated populations.
All methods considered here showed elevated SARs, suggesting
this is a general phenomenon that should be considered in the
design, analysis, and interpretation of rare variant association
studies.
Supporting Information
File S1 This file contains additional figures and tables
that support the conclusions made in the main text. It
also contains a detailed explanation of the ESP Banner and an
extended acknowledgements section.
(PDF)
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